Is Blue Jet Healthcare the Best Stock in Its Sector? A Look at the Numbers
- September 24, 2026
- Posted by: Kunal Singla
- Category: Market
Blue Jet Healthcare CMP Rs 584 (24 Sep 2026). Market cap Rs 11,075 Cr. ROE 18.22%. P/E 47.15x versus Industry P/E 51.57x.
Quick Answer
Blue Jet Healthcare is one of the names investors compare when screening the Healthcare sector, built on a 18.22% return on equity and a P/E of 47.15x against an Industry P/E of 51.57x. Whether Blue Jet Healthcare is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.
Is Blue Jet Healthcare the best stock in its sector? The stock trades on the NSE at Rs 584 as of 24 September 2026, within its 52-week range of Rs 325.00 to Rs 692.90. Blue Jet Healthcare Ltd manufactures specialty pharmaceutical intermediates and contrast media ingredients for the imaging and diagnostics industry.
Blue Jet Healthcare sits in the Healthcare sector, and its 18.22% ROE and 47.15x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P/E benchmark.
Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers
Click Here – Get Free Investment Predictions
About Blue Jet Healthcare
Blue Jet Healthcare Ltd manufactures specialty pharmaceutical intermediates and contrast media ingredients for the imaging and diagnostics industry. It manufactures specialty pharmaceutical intermediates and contrast media ingredients, a niche CDMO segment focused on the imaging and diagnostics industry. At a market capitalisation of Rs 11,075 Cr, it is tracked as part of the Healthcare sector on Univest.
Is Blue Jet Healthcare the Best Stock in Its Sector?
Blue Jet Healthcare makes its case as the best stock in its sector primarily on return on equity and balance sheet strength, combining a 18.22% ROE with a 47.15x P/E against the sector’s 51.57x Industry P/E. Blue Jet Healthcare trades close to its 51.57x Industry P/E, with an 18.22% ROE ahead of Bliss GVS Pharma’s in this comparison, reflecting its specialised contrast media and imaging ingredients niche.
| Metric | Blue Jet Healthcare |
|---|---|
| CMP (NSE) | Rs 583.50 |
| 52-Week High / Low | Rs 692.90 / Rs 325.00 |
| Market Cap | Rs 11,075 Cr |
| P/E (TTM) vs Industry P/E | 47.15x vs 51.57x |
| P/B | 5.13 |
| ROE | 18.22% |
| EPS (TTM) | Rs 12.41 |
| Dividend Yield | 0.19% |
| Debt to Equity | 0.03 |
Compare Blue Jet Healthcare Against Other Healthcare Sector Stocks
How Blue Jet Healthcare Compares Against Its Healthcare Sector Peers
The table below sets Blue Jet Healthcare against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.
| Company | Market Cap (Rs Cr) | P/E | ROE | Debt to Equity |
|---|---|---|---|---|
| Blue Jet Healthcare | 11,075 | 47.15 | 18.22% | 0.03 |
| Bliss GVS Pharma | 7,411 | 52.28 | 10.82% | 0.02 |
| Beta Drugs | 2,425 | 52.41 | 16.95% | 0.60 |
| Peer average (2 companies) | – | 52.34 | 13.88% | 0.31 |
Against this peer set, Blue Jet Healthcare’s 18.22% ROE is above the 13.88% peer average, and its P/E of 47.15x runs below the peer average of 52.34x. Blue Jet Healthcare trades close to its 51.57x Industry P/E, with an 18.22% ROE ahead of Bliss GVS Pharma’s in this comparison, reflecting its specialised contrast media and imaging ingredients niche.
What Makes Blue Jet Healthcare Worth Watching in Healthcare
- Close to Industry P/E: A 47.15x P/E versus a 51.57x Industry P/E shows the stock trading close to Healthcare sector norms.
- Strong ROE: An 18.22% ROE is well above most CDMO and API peers covered in this series.
- Near debt free: A debt to equity ratio of 0.03 gives Blue Jet Healthcare flexibility to invest in manufacturing capacity.
Blue Jet Healthcare Valuation: Is It Justified?
Blue Jet Healthcare trades close to its 51.57x Industry P/E, with an 18.22% ROE ahead of Bliss GVS Pharma’s in this comparison, reflecting its specialised contrast media and imaging ingredients niche. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.
Also read – Is Bharat Bijlee the Best Stock in Its Sector? A Look at the Numbers
Download the Univest iOS App or Univest Android App to track Blue Jet Healthcare and other Healthcare sector stocks.
How to Track Blue Jet Healthcare Before You Invest
Before deciding whether Blue Jet Healthcare deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.
- Open the Univest Screener and search for Blue Jet Healthcare to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
- Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
- Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
- Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.
Conclusion
Blue Jet Healthcare earns a place in the best stock in its sector conversation on the strength of a 18.22% ROE and a P/E of 47.15x against a 51.57x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Is Blue Jet Healthcare the best stock in its sector?
Ans. Blue Jet Healthcare has a 18.22% ROE and trades at 47.15x P/E against a 51.57x Industry P/E, and compares above the peer average ROE of 13.88% in this article’s named comparison, so the answer depends on what an investor is prioritising.
What is the current share price of Blue Jet Healthcare?
Ans. Blue Jet Healthcare was trading at Rs 583.50 on the NSE as of 24 September 2026, within its 52-week range of Rs 325.00 to Rs 692.90.
What sector does Blue Jet Healthcare belong to?
Ans. Blue Jet Healthcare is classified under the Healthcare sector on Univest.
How does Blue Jet Healthcare compare to its sector peers on P/E?
Ans. Blue Jet Healthcare’s P/E of 47.15x is below the 52.34x average of the 2 named peers compared in this article.
What is Blue Jet Healthcare’s return on equity?
Ans. Blue Jet Healthcare reported a return on equity of 18.22%, which is above the 13.88% average of its named peers in this comparison.
Should I invest in Blue Jet Healthcare based on its sector position?
Ans. Blue Jet Healthcare’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.
